Month: September 2020

NEW YORK, Sept. 22, 2020 (GLOBE NEWSWIRE) — Renalytix AI, Inc. (LSE: RENX) (NASDAQ: RNLX), an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease to drive improved patient outcomes and advance value-based care, announced today that it has received a California Clinical Laboratory License from the California Department of Health for its clinical laboratory in Salt Lake City, Utah. KidneyIntelX™ may now be used to report risk assessment of progressive decline in kidney function for patients in California with early stage diabetic kidney disease (DKD). With this certification, the Company is now licensed to provide KidneyIntelX testing services for patients in 49 states.According to the American Society of Nephrology, California has more than five million patients...

BURLINGAME, Calif., Sept. 22, 2020 (GLOBE NEWSWIRE) — ALX Oncology (NASDAQ:ALXO), a clinical-stage immuno-oncology company developing therapies that block the CD47 checkpoint pathway, today announced it has entered into a clinical trial collaboration with Merck, known as MSD outside the United States and Canada, to evaluate the combination of ALX148, an investigational next generation CD47 blocker, and KEYTRUDA® (pembrolizumab), Merck’s anti-PD-1 therapy, for the treatment of patients with Head & Neck Squamous Cell Carcinoma (HNSCC).Under the terms of the agreement, ALX Oncology will conduct a Phase 2 program comprising two separate Phase 2 studies. The first study will evaluate the efficacy of ALX148 in combination with KEYTRUDA for the first line treatment of patients with PD-L1 expressing metastatic or unresectable, recurrent...

VIRGINIA CITY, Nev., Sept. 22, 2020 (GLOBE NEWSWIRE) — Comstock Mining Inc. (the “Company”) (NYSE American: LODE) announced today that Geotech Ltd. (“Geotech”) of Aurora, Canada, began conducting the previously announced airborne geophysical surveys last weekend, including the Dayton resource area, adjacent to Silver City, NV and the contiguous Spring Valley exploration targets all the way to Hwy 50.  Geotech launched its proprietary Versatile Time-Domain Electromagnetic (“VTEM”) geophysical system on Saturday, September 19, 2020, once visibility improved as smoke from the California fires cleared, and plans to complete the survey, by the end of September. The Company expects preliminary scans becoming available by mid-October, and extensive three-dimensional interpreted results later in the fourth quarter.A photo accompanying this...

WATERLOO, Ontario, Sept. 22, 2020 (GLOBE NEWSWIRE) — Descartes Systems Group (Nasdaq:DSGX) (TSX:DSG), the global leader in uniting logistics-intensive businesses in commerce, announced that Lake Forest, IL-based Brook Furniture Rental, a leading provider of rental furnishings for the office and home, selected Descartes’ delivery appointment scheduling and execution solution to improve its white glove delivery operations across 12 distribution centers in the U.S.“Our services include expert set-up at a time that works for our customers. Delivery appointment scheduling is a critical part of our service, whether we’re delivering a full home worth of furnishings to an individual or a complete office solution for a commercial client,” said Nathan Sanders, President & CEO at Brook Furniture Rental. “The Descartes solution is a powerful...

TORONTO and CAMBRIDGE, Mass., Sept. 22, 2020 (GLOBE NEWSWIRE) — ProMIS Neurosciences, Inc. (TSX: PMN) (OTCQB: ARFXF), a biotechnology company focused on the discovery and development of antibody therapeutics targeting toxic oligomers implicated in the development of neurodegenerative diseases, announced today initiation of a program to construct and test a multivalent peptide vaccine for Alzheimer’s disease (AD). The critical first steps in vaccine development will be carried out by VIDO-InterVac, a global leader in vaccine research and development.Recent progress in the development of blood-based biomarkers for neurodegeneration is enabling increased screening to diagnose and identify individuals at risk of developing AD. A vaccine capable of inducing an effective antibody response against amyloid-beta toxic oligomers (ABOs) could...

CHICAGO, Sept. 22, 2020 (GLOBE NEWSWIRE) — Billy Bosworth has been named to the TransUnion (NYSE: TRU) Board of Directors, effective Sept. 21.“Billy is an innovative technology leader, and we’re excited about the opportunity to add him to TransUnion’s Board,” said Pamela Joseph, Chairperson of the Board. “Technology is a key component in our work to deliver Information for Good, and Billy’s expertise will augment our Board capabilities as we continue to make trust possible between consumers and businesses.” Bosworth, 51, is the CEO of Dremio Corporation, a privately held company in the data analytics market. He has been the CEO since Feb. 2020, and joined the Dremio Board of Directors in August 2019. Throughout his career in the technology sector, Bosworth has served in many roles, ranging from software engineer to CEO. He has particular...

AB Ignitis Grupė, (hereinafter – Ignitis Grupė or „the Company”) identification code 301844044, registered office placed at Žvejų str. 14, Vilnius, Republic of Lithuania. The total nominal value of issued bonds 900 000 000 EUR; ISIN codes XS1646530565; XS1853999313; XS2177349912.Ignitis Group, the leading energy company in the Baltic region, which announced price range for the planned offering and the Prospectus on Monday, is inviting retail investors to participate in the virtual presentation of this process. On 23 September the representatives of the company will provide more details about the ongoing IPO and answer questions from investors.Retail investors in Lithuania, Latvia and Estonia can participate in IPO of Ignitis Group. They can register for presentations on the company’s website at https://ignitisevents.lt/.Virtual...

AB „Ignitis grupė“ (toliau – „Ignitis grupė“ ir Bendrovė), juridinio asmens kodas: 301844044, registruotos buveinės adresas: Žvejų g. 14, Vilnius. Bendra  „Ignitis grupės“ išleistų obligacijų nominali vertė 900 000 000 EUR; ISIN kodai: XS1646530565; XS1853999313; XS2177349912.Baltijos regione pirmaujanti energetikos bendrovė „Ignitis grupė“, pirmadienį paskelbusi pirminio viešo akcijų siūlymo (ang. Initial Public Offering, IPO) kainos intervalą ir Prospektą, mažmeninius investuotojus kviečia dalyvauti virtualiame šio proceso pristatyme. Rugsėjo 23 d. bendrovės atstovai jame pateiks daugiau detalių apie vykstantį IPO ir atsakys į investuotojams kylančius klausimus.Dalyvauti „Ignitis grupės“ IPO yra kviečiami Lietuvoje, Latvijoje ir Estijoje gyvenantys mažmeniniai investuotojai. Jie į pristatymus užsiregistruoti gali bendrovės svetainėje...